These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1005 related items for PubMed ID: 12095383

  • 1. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.
    Dorenbaum A, Cunningham CK, Gelber RD, Culnane M, Mofenson L, Britto P, Rekacewicz C, Newell ML, Delfraissy JF, Cunningham-Schrader B, Mirochnick M, Sullivan JL, International PACTG 316 Team.
    JAMA; 2002 Jul 10; 288(2):189-98. PubMed ID: 12095383
    [Abstract] [Full Text] [Related]

  • 2. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N, van der Merwe L, Brocklehurst P, Sint TT.
    Cochrane Database Syst Rev; 2011 Jul 06; (7):CD003510. PubMed ID: 21735394
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
    Taha TE, Kumwenda NI, Hoover DR, Fiscus SA, Kafulafula G, Nkhoma C, Nour S, Chen S, Liomba G, Miotti PG, Broadhead RL.
    JAMA; 2004 Jul 14; 292(2):202-9. PubMed ID: 15249569
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Brocklehurst P, Volmink J.
    Cochrane Database Syst Rev; 2002 Jul 14; (1):CD003510. PubMed ID: 11869666
    [Abstract] [Full Text] [Related]

  • 7. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.
    Lallemant M, Jourdain G, Le Coeur S, Mary JY, Ngo-Giang-Huong N, Koetsawang S, Kanshana S, McIntosh K, Thaineua V, Perinatal HIV Prevention Trial (Thailand) Investigators.
    N Engl J Med; 2004 Jul 15; 351(3):217-28. PubMed ID: 15247338
    [Abstract] [Full Text] [Related]

  • 8. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS, Dokubo EK, Sint TT.
    Cochrane Database Syst Rev; 2010 Mar 17; (3):CD008440. PubMed ID: 20238370
    [Abstract] [Full Text] [Related]

  • 9. A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.
    Thistle P, Spitzer RF, Glazier RH, Pilon R, Arbess G, Simor A, Boyle E, Chitsike I, Chipato T, Gottesman M, Silverman M.
    Clin Infect Dis; 2007 Jan 01; 44(1):111-9. PubMed ID: 17143826
    [Abstract] [Full Text] [Related]

  • 10. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    Kesho Bora Study Group, de Vincenzi I.
    Lancet Infect Dis; 2011 Mar 01; 11(3):171-80. PubMed ID: 21237718
    [Abstract] [Full Text] [Related]

  • 11. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
    Thior I, Lockman S, Smeaton LM, Shapiro RL, Wester C, Heymann SJ, Gilbert PB, Stevens L, Peter T, Kim S, van Widenfelt E, Moffat C, Ndase P, Arimi P, Kebaabetswe P, Mazonde P, Makhema J, McIntosh K, Novitsky V, Lee TH, Marlink R, Lagakos S, Essex M, Mashi Study Team.
    JAMA; 2006 Aug 16; 296(7):794-805. PubMed ID: 16905785
    [Abstract] [Full Text] [Related]

  • 12. Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.
    Suksomboon N, Poolsup N, Ket-Aim S.
    J Clin Pharm Ther; 2007 Jun 16; 32(3):293-311. PubMed ID: 17489882
    [Abstract] [Full Text] [Related]

  • 13. Perinatal Antiretroviral Intensification to Prevent Intrapartum HIV Transmission When Antenatal Antiretroviral Therapy Is Initiated Less Than 8 Weeks Before Delivery.
    Lallemant M, Amzal B, Sripan P, Urien S, Cressey TR, Ngo-Giang-Huong N, Klinbuayaem V, Rawangban B, Sabsanong P, Siriwachirachai T, Jarupanich T, Kanjanavikai P, Wanasiri P, Koetsawang S, Jourdain G, Le Coeur S, PHPT-5 site investigators.
    J Acquir Immune Defic Syndr; 2020 Jul 01; 84(3):313-322. PubMed ID: 32205720
    [Abstract] [Full Text] [Related]

  • 14. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
    Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, Nikodem C, Hall D, Gigliotti M, Robinson P, Boshoff L, Sullivan JL, South African Intrapartum Nevirapine Trial (SAINT) Investigators.
    J Infect Dis; 2003 Mar 01; 187(5):725-35. PubMed ID: 12599045
    [Abstract] [Full Text] [Related]

  • 15. Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine.
    Stringer JS, Sinkala M, Chapman V, Acosta EP, Aldrovandi GM, Mudenda V, Stout JP, Goldenberg RL, Kumwenda R, Vermund SH.
    AIDS; 2003 Jul 25; 17(11):1659-65. PubMed ID: 12853748
    [Abstract] [Full Text] [Related]

  • 16. Single-dose Nevirapine during pregnancy.
    Sax PE.
    AIDS Clin Care; 1999 Oct 25; 11(10):84-5. PubMed ID: 11366708
    [Abstract] [Full Text] [Related]

  • 17. Nevirapine: a review of its use in the prevention and treatment of paediatric HIV infection.
    Bardsley-Elliot A, Perry CM.
    Paediatr Drugs; 2000 Oct 25; 2(5):373-407. PubMed ID: 11022799
    [Abstract] [Full Text] [Related]

  • 18. A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).
    Musoke P, Guay LA, Bagenda D, Mirochnick M, Nakabiito C, Fleming T, Elliott T, Horton S, Dransfield K, Pav JW, Murarka A, Allen M, Fowler MG, Mofenson L, Hom D, Mmiro F, Jackson JB.
    AIDS; 1999 Mar 11; 13(4):479-86. PubMed ID: 10197376
    [Abstract] [Full Text] [Related]

  • 19. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.
    Jackson JB, Musoke P, Fleming T, Guay LA, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Owor M, Ducar C, Deseyve M, Mwatha A, Emel L, Duefield C, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Gigliotti M, Bray D, Mmiro F.
    Lancet; 2003 Sep 13; 362(9387):859-68. PubMed ID: 13678973
    [Abstract] [Full Text] [Related]

  • 20. Prevention of perinatal HIV infection: cause for optimism.
    Lindsay MK.
    AIDS Clin Care; 1999 Dec 13; 11(12):95-7, 99, 102. PubMed ID: 11366712
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 51.